Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
MannKind Corporation, headquartered in the U.S., is a leading biopharmaceutical company specializing in the development of innovative inhalation therapies. Through cutting-edge drug delivery technologies, MannKind is sustainably improving the treatment of diabetes and rare lung diseases.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
MannKind is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
MannKind last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.06 USD.
MannKind has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.